Benign and malignant pheochromocytoma: Diagnosis, treatment, and follow- up

Surgical Oncology Clinics of North America

Volumn 7, Issue 4, 1998, Pages 765-789

  Kebebew, E ^a   Duh, Q Y ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDROXYCORTIDE; LABETALOL; METIROSINE; PRAZOSIN;

ADRENALECTOMY; CANCER INCIDENCE; CATECHOLAMINE URINE LEVEL; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; HEART ARRHYTHMIA; HISTOPATHOLOGY; HUMAN; HYPERTENSION; PHEOCHROMOCYTOMA; REVIEW; SERODIAGNOSIS; SEX DIFFERENCE; TUMOR LOCALIZATION;

EID: 0031752341     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30244-8     Document Type: Review

References (81)

1. Averbuch S.D. Steakley C.S. Young R.C. Malignant pheochromocytoma: Effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine Ann Intern Med 109 1988 267
2. Bravo E.L. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma Endocr Rev 15 1994 3
3. Canale M.P. Bravo E.L. Diagnostic specificity of serum chromogranin-A for pheochromocytoma in patients with renal dysfunction J Clin Endocrinol Metab 78 1994 5
4. Carney J.A. The triad of gastric epithelioid leiomyosarcoma, pulmonary chondroma, and functioning extra-adrenal paraganglioma: A 5-year review Medicine 62 1983 3
5. Caty M.G. Coran A.G. Geagen M. Current diagnosis and treatment of pheochromocytoma in children Arch Surg 125 1990 978
6. Chew S.L. Lavender P. Jain A. Absence of mutations in the MEN 2A region of the ret proto-oncogene in non-MEN 2A pheochromocytomas Clin Endocrinol 42 1995 1
7. Doppman J.L. Reinig J.W. Dwyer A.J. Differentiation of adrenal masses by magnetic resonance imaging Surgery 102 1987 6
8. Duh Q.Y. Siperstein A.E. Clark O.H. Laparoscopic adrenalectomy: Comparison of the lateral and posterior approaches Arch Surg 131 1996 870
9. Francis I.R. Gross M.D. Shapiro B. Integrated imaging of adrenal disease Radiology 184 1992 1
10. Freier D.T. Thompson N.W. Pheochromocytoma and pregnancy: The epitome of high risk Surgery 114 1993 6
11. Gagner M. Breton G. Pharand D. Is laparoscopic adrenalectomy indicated for pheochromocytoma? Surgery 120 1996 6
12. Graham P.E. Smythe G.A. Edwards G.A. Laboratory diagnosis of phaeochromocy- toma: Which analytes should we measure? Ann Clin Biochem 30 1993 129
13. Grant C.S. Pheochromocytoma Clark O.H. Duh Q.Y. Textbook of Endocrine Surgery 1997 WB Saunders Philadelphia 513
14. Grossman E. Goldstein D.S. Hoffman A. Glucagon and clonidine testing in the diagnosis of pheochromocytoma Hypertension 17 1991 733
15. Grouzmann E. Giequel C. Pluin P.F. Neuropeptide Y and neuron specific enolase levels in benign and malignant pheochromocytoma Cancer 66 1990 1833
16. Gutmann D.H. Geist R.T. Rose K. Loss of neurofibromatosis type I (NFI) gene expression in pheochromocytomas from patients without NFI Genes Chromosomes Cancer 13 1995 104
17. Heaney A.P. O’Rourke D. Arthur K. Flow cytometric analysis does not reliably differentiate benign from malignant pheochromocytoma Clin Endocrinol 44 1996 233
18. Helman L.J. Cohen P.S. Averbuch S.D. Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma J Clin Oncol 7 1989 1720
19. Horgan S. Sinanan M. Helton W.S. Use of laparoscopic techniques improves outcome from adrenalectomy Am J Surg 173 1997 371
20. Howe J.R. Norton J.A. Wells S.A. Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: Results of long-term follow-up Surgery 114 1993 6
21. Hsing A.W. Nam J.M. Co Chien H.T. Risk factors for adrenal cancer: An exploratory study Int J Cancer 65 1996 4
22. Irvin G.L. Fishman L.M. Sher J.A. Pheochromocytoma: Lateral versus anterior operative approach Ann Surg 209 1989 6
23. Komminoth P. Roth J. Muletta-Feurer S. RET proto-oncogene point mutations in sporadic neuroendocrine tumors J Clin Endocrinol Metab 81 1996 6
24. Kopf D. Bockisch A. Steinert H. Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant pheochromocytoma Clin Endocrinol 46 1997 39
25. Krempf M. Lumbroso J. Mornex R. Use of m-[I-131]iodobenzylguanidine in the treatment of malignant pheochromocytoma J Clin Endocrinol Metab 72 1991 2
26. Kvale W.F. Roth G.M. Manger W.M. Pheochromocytoma Circulation 14 1956 622
27. Lairmore T.C. Ball D.W. Baylin S.B. Management of pheochromocytomas in patients with multiple endocrine neoplasia Type 2 syndromes Ann Surg 217 1993 6
28. Lamberts S.W.J. Bakker W.H. Reubi J.C. Somatostatin-receptor imaging in the localization of endocrine tumors N Engl J Med 323 1990 18
29. Lastoria S. Maurea S. Vergara E. Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors Q J Nucl Med 39 1995 4 Suppl 1
30. Lee J.E. Curley S.A. Gagel R.F. Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma Surgery 120 1996 6
31. Limouris G.S. Giannakopoulos V. Stavraka A. Comparison of In-111 pentetreotide, Tc-99m(V)DMSA and I-123 MIBG scintimaging in neural crest tumors Anticancer Res 17 1997 1589
32. Liu Q. Djuricin G. Staren E.D. Tumor angiogenesis in pheochromocytoma and paragangliomas Surgery 120 1996 6
33. Liu J. Voutilainen R. Kahri A.I. Expression patterns of the c-myc gene in adrenocortical tumors and pheochromocytomas J Endocrinol 152 1997 175
34. Lynn M.D. Braunstein E.M. Wahl R.L. Bone metastases in pheochromocytoma: Comparative studies of efficacy of imaging Radiology 160 1986 3
35. Mahoney E.M. Harrison J.H. Malignant pheochromocytoma: Clinical course and treatment J Urol 118 1977 225
36. Maurea S. Cuocolo A. Reynolds J.C. Diagnostic imaging in patients with paragangliomas: Computed tomography, magnetic resonance and MIBG scintigraphy comparison Q J Nucl Med 40 1996 4
37. Maurea S. Lastoria S. Caraco C. The role radiolabeled somatostatin analogs in adrenal imaging Nucl Med Biol 23 1996 6
38. McCorkell S.J. Niles N.L. Fine-needle aspiration of catecholamine-producing adrenal masses: A possibly fatal mistake Am J Radiol 145 1985 113
39. Nativ O. Grant C.S. Sheps S.G. The clinical significance of nuclear DNA ploidy pattern in 184 patients with pheochromocytoma Cancer 69 1991 11
40. Neumann H.P. Berger D.P. Sigmund G. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease J Med 331 1994 22
41. Orchard T. Grant C.S. van Heerden J.A. Pheochromocytoma-continuing evolution of surgical therapy Surgery 114 1993 6
42. O’Riordain D.S. Young W.F. Grant C.S. Clinical spectrum and outcome of functional extra-adrenal paraganglioma World J Surg 20 1996 7
43. Pang L.C. Tsao K.C. Flow cytometric DNA analysis for the determination of malignant potential in adrenal and extra-adrenal pheochromocytomas or paragangliomas Arch Pathol Lab Med 117 1993 11
44. Peplinski G.R. Norton J.A. The predictive value of diagnostic tests for pheochromocytoma Surgery 116 1994 6
45. Platts J.K. Drew P.J.T. Harvey J.N. Death from pheochromocytoma: lessons from a postmortem survey J R Coll Physicians Lond 29 1995 4
46. Pommier R.F. Brennan M.F. Management of adrenal neoplasms Curr Probl Surg 28 1991 657
47. Pommier R.F. Vetto J.T. Billings K. Comparison of adrenal and extra-adrenal pheochromocytomas Surgery 114 1993 6
48. Proye C.A.G. Huart J.Y. Cuvillier S.D. Safety of the posterior approach in adrenal surgery: Experience in 105 cases Surgery 114 1993 6
49. Proye C.A. Vix M. Jansson S. “The” pheochromocytoma: A benign, intra-adrenal, hypertensive, sporadic unilateral tumor World J Surg 18 1994 4
50. Quint L.E. Glazer G.M. Graneis I.R. Pheochromocytoma and paraganglioma: Comparison of MR imaging with CT and I-131 MIBG scintigraphy Radiology 165 1987 1
51. Richard S. Beigelman C. Duclos J.M. Pheochromocytoma as the first manifestation of von Hippel-Lindau disease Surgery 116 1994 6
52. Rosano T.G. Swift T.A. Hayes L.W. Advances in catecholamine and metabolite measurements for diagnosis of pheochromocytoma Clin Chem 37 1991 10
53. Sakai C. Takagi T. Oguro M. Malignant pheochromocytoma accompanied by microangiopathic hemolytic anemia: A case report Jpn J Clin Oncol 24 1994 3
54. Samaan N.A. Hickey R.C. Shutts P.E. Diagnosis, localization, and management of pheochromocytoma: Pitfalls and follow-up in 41 patients Cancer 62 1988 11
55. Shapiro B. Sisson J.C. Lloyd R. Malignant pheochromocytoma: Clinical, biochemical and scintigraphic characterization Clin Endocrinol 20 1984 189
56. Shapiro B. Sisson J.C. Shulkin B.L. The current status of meta-iodo-benzylguanidine and related agents for the diagnosis of neuro-endocrine tumors Q J Nucl Med 39 1995 4 Suppl 1
57. Shapiro B. Sisson J.C. Shulkin B.L. The current status of radioiodinated meta-iodo- benzylguanidine therapy of neuro-endocrine tumors Q J Nucl Med 34 1995 4 Suppl 1
58. Sheps S.G. Jiang N-S Klee G.G. Diagnostic evaluation of pheochromocytoma Endocrinol Metab Clin North Am 17 1988 2
59. Sheps S.G. Jiang N.S. Klee G.G. Recent developments in the diagnosis and treatment of pheochromocytoma Mayo Clin Proc 65 1990 88
60. Siddiqui M.Z. Von Eyben F.E. Spanos G. High-voltage irradiation and combination chemotherapy for malignant pheochromocytoma Cancer 62 1988 4
61. Smythe G.A. Edwards G. Graham P. Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine Clin Chem 38 1992 486
62. Staren E.D. Prinz R.A. Adrenalectomy in the era of laparoscopy Surgery 120 1996 4
63. Stenstrom G. Svardsudd K. Pheochromocytoma in Sweden 1958-1981: An analysis of the National Cancer Registry data Acta Medica Scandinavica 220 1986 225
64. Stridsberg M. Husebye E.S. Chromogranin A and chromogranin B are sensitive circulating markers for pheochromocytoma Eur J Endocrinol 136 1997 1
65. Sutton M.G.S. Sheps S.G. Lie J.T. Prevalence of clinically unsuspected pheochromocytoma: Review of a 50-year autopsy series Mayo Clin Proc 56 1981 354
66. Suzuki K. Kageyama S. Ueda D. Laparoscopic adrenalectomy: Clinical experience with 12 cases J Urol 150 1993 1099
67. Tanaka S. Ito T. Tomoda J. Malignant pheochromocytoma with hepatic metastasis diagnosed 20 years after resection of the primary adrenal lesion Intern Med 32 1993 10
68. Tato A. Orte L. Diz P. Malignant pheochromocytoma, still a therapeutic challenge Am J Hypertension 10 1997 4
69. Tenenbaum F. Lumbroso J. Schlumberger M. Comparison of radiolabeled octreotide and meta-iodo-benzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma J Nucl Med 36 1995 1
70. Tibblin S. Dymling J.F. Ingemansson S. Unilateral versus bilateral adrenalectomy in multiple endocrine neoplasia IIA World J Surg 7 1983 2
71. 131I-MIBG therapy of neural crest tumours (review) Anticancer Res 17 1997 1823
72. van Heerden J.A. Roland C.F. Carney A. Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s) World J Surg 14 1990 3
73. van Heerden J.A. Sizemore G.W. Carney J.A. Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome World J Surg 8 1984 4
74. Velchik M.G. Alavi A. Kressel H.Y. Localization of pheochromocytoma: MIBG, CT, and MRI correlation J Nucl Med 30 1989 3
75. Werbel S.S. Ober K.P. Pheochromocytoma: Update on diagnosis, localization, and management Med Clin North Am 79 1995 1
76. Webb T.A. Sheps S.G. Carney J.A. Differences between sporadic pheochromocytoma and pheochromocytoma in multiple endocrine neoplasia, type 2 Am J Surg Pathol 4 1980 2
77. Welbourn R.B. Early surgical history of pheochromocytoma Br J Surg 74 1987 7
78. Welbourn R.B. The adrenal glands Welbourn R.B. The History of Endocrine Surgery 1990 Praeger New York 147 215
79. Whalen R.K. Althausen A.F. Daniels G.H. Extra-adrenal pheochromocytoma J Urol 147 1992 1 10
80. Wiseman G.A. Kvols L.K. Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues Semin Nucl Med 25 1995 3
81. Zeiger M.A. Zbar B. Keiser H. Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated and familial pheochromocytoma Genes Chromosomes Cancer 13 1995 3